Beverage sector acquisitions propel Tilray stock to a 3.28% rise

Traders Union
All News
Financial News
Tilray gains 3.28% today to $6.94

Highlights

Tilray's third-quarter revenue rose 11% year-over-year to $207 million, largely driven by beverage acquisitions rather than cannabis growth.
The company reported a quarterly loss of $0.24 per share, while Signaturefd LLC significantly trimmed its stake in Tilray.
Shares trade in a short-term bullish pattern with intraday momentum, but mixed indicators signal likely sideways or downward movement in the $6.65–$7.20 range over the next week.

Acquisition-driven revenue growth as cannabis remains flat and losses widen

On April 1, Tilray reported third-quarter results for fiscal 2026, with net revenue reaching $207 million, an increase of 11% year-over-year. The company’s growth was mainly supported by acquisitions in the beverage sector, while its core cannabis division remained stagnant. Tilray also posted a quarterly loss of $0.24 per share during the same period, with additional disclosure that Signaturefd LLC significantly reduced its holdings in the company.

Overbought conditions and mixed momentum signal risk of near-term pullback

The current price of $6.94 trades above the MA-20 ($6.57), but remains below the MA-50 ($7.13) and well under the MA-200 ($9.67). This configuration suggests a short-term bullish bias, but medium- and long-term trends remain under pressure from sellers. The Ichimoku Kijun level is at $6.72, acting as immediate support just below current levels.

Momentum signals are mixed: the MACD on D1 shows a strong sell, while ADX remains neutral, reflecting weak trend strength. The RSI is in neutral territory but leans slightly bearish at 48.66, while Stoch RSI signals overbought (99.26), pointing to stretched short-term upside; CCI is near neutral at 12.04. BBP indicates strong buyer dominance intraday, and the Awesome Oscillator is neutral. Today’s session opened at $6.93, a minor gap above the previous close of $6.72, and the price is currently near the upper end of today’s range ($6.86–$7.07), reflecting a 3.28% gain amid moderate volatility and upward momentum toward session highs. The conflicting signals between overbought oscillators and positive BBP and price action point to divergence, suggesting potential for short-term pullback or consolidation despite intraday strength.

Downside favored as break below support could trigger more selling

For the next five trading days, the expected price range is $6.65–$7.20, adjusted for a typical volatility band relative to current levels. The probability of a move higher is very low (less than 20%), making a downward move more likely in the short term. Baseline scenario: the price oscillates sideways in the $6.65–$7.20 band. Bullish scenario: a break above $7.20 could open quick tests of higher resistance, though this has a low likelihood given current signals. Bearish scenario: a drop below $6.65 would expose the stock to further selling, especially if momentum turns downward and support at the Ichimoku Kijun level fails.

Anton Kharitonov, expert at Traders Union, sees Tilray’s short-term strength as purely technical, supported by its position above the MA-20 and intraday momentum. He notes that the wider technical structure and weak core cannabis performance keep downside risks elevated. Momentum indicators and overbought oscillators suggest a fragile upside, while institutional outflows add pressure. "With the price stuck below key averages and fundamentals lacking improvement, I expect Tilray to consolidate or weaken toward $6.65 unless buyers reclaim $7.20 with strong volume."

Earlier, analysts noted that Tilray remained under medium- and long-term bearish pressure despite operational improvements and efforts to diversify its portfolio. The latest results and technical signals confirm this broader weakness, pointing to a heightened risk of near-term consolidation or pullback unless the price can sustain a decisive breakout above $7.20.

Source of Data: TLRY Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.